TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04745481

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Trunk stabilization training device
Description: Conventional rehabilitation 30min daily, 20times 4weeks~+Trunk stabilization training device 30min daily, 20time 4weeks

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional rehabilitation
Description: Conventional rehabilitation 30min daily, 20times 4weeks~+Conventional rehabilitation 30min daily, 20times 4weeks
Study: NCT05389566

Intervention type: DIAGNOSTIC_TEST
Intervention: Composite Autonomic Symptom Score 31
Description: Evaluation of autonomic neuropathy

Intervention type: DIAGNOSTIC_TEST
Intervention: Computerized dynamic posturography
Description: Evaluation of dynamic postural control

Intervention type: DIAGNOSTIC_TEST
Intervention: Computerized dynamic posturography
Description: Evaluation of dynamic postural control

Intervention type: DIAGNOSTIC_TEST
Intervention: Computerized dynamic posturography
Description: Evaluation of dynamic postural control

Intervention type: DIAGNOSTIC_TEST
Intervention: Video Head Impulse Test
Description: Evaluation of vertigo and the vestibular organ

Intervention type: DIAGNOSTIC_TEST
Intervention: Video Head Impulse Test
Description: Evaluation of vertigo and the vestibular organ

Intervention type: DIAGNOSTIC_TEST
Intervention: Video Head Impulse Test
Description: Evaluation of vertigo and the vestibular organ

Intervention type: DIAGNOSTIC_TEST
Intervention: Accelerometer
Description: Evaluation of gait pattern

Intervention type: DIAGNOSTIC_TEST
Intervention: Accelerometer
Description: Evaluation of gait pattern
Study: NCT05241964

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PRP
Description: 4\~6ml autologous platelet rich plasma injection every 14±2 days for a total of 5 injections.
Study: NCT05782049

Intervention type: OTHER
Group type: OTHER
Intervention: Ultrasound of the salivary glands
Description: Salivary gland ultrasound is, a non-invasive, non-irradiating and easily accessible examination, offers promising results for the diagnosis of primary SS. It allows the identification of changes in the homogeneity of the echostructure of the main salivary glands in the parotid and submandibular region.The patient lies on the examination table with the head slightly turned to the side opposite the gland being examined. The examination will be done on the parotid and submandibular glands on both sides.The parotid glands will be measured in length and width.The surface of the gland will be calculated: (length x width)/2.The sub-maxillary glands will be measured in length and surface.~The exam will be performed in 10 minutes.

Intervention type: OTHER
Group type: OTHER
Intervention: Ultrasound of the salivary glands
Description: Salivary gland ultrasound is, a non-invasive, non-irradiating and easily accessible examination, offers promising results for the diagnosis of primary SS. It allows the identification of changes in the homogeneity of the echostructure of the main salivary glands in the parotid and submandibular region.The patient lies on the examination table with the head slightly turned to the side opposite the gland being examined. The examination will be done on the parotid and submandibular glands on both sides.The parotid glands will be measured in length and width.The surface of the gland will be calculated: (length x width)/2.The sub-maxillary glands will be measured in length and surface.~The exam will be performed in 10 minutes.

Intervention type: OTHER
Group type: OTHER
Intervention: Measurement of salivary flow
Description: Saliva flow measurement, which consists of measuring the quantity of saliva that the patient can emit in 15 minutes

Intervention type: OTHER
Group type: OTHER
Intervention: Measurement of salivary flow
Description: Saliva flow measurement, which consists of measuring the quantity of saliva that the patient can emit in 15 minutes

Intervention type: OTHER
Group type: OTHER
Intervention: A Schirmer test
Description: A strip of blotting paper graduated from five to five millimeters is placed in the eye for 5 minutes, avoiding any corneal contact.

Intervention type: OTHER
Group type: OTHER
Intervention: A Schirmer test
Description: A strip of blotting paper graduated from five to five millimeters is placed in the eye for 5 minutes, avoiding any corneal contact.
Study: NCT05079022

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furmonertinib
Description: Furmonertinib at 80mg dose will be administered orally once daily.
Study: NCT03617744

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sleeve gastrectomy
Description: Open sleeve gastrectomy
Study: NCT05280418

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Tezepelumab
Description: Monoclonal antibody designed for the treatment asthma.

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matched placebo.
Study: NCT05514912

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Given IV

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine Hydrochloride
Description: Given IV

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine Hydrochloride
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Infigratinib Phosphate
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: Given IV

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab-paclitaxel
Description: Given IV
Study: NCT04833764

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Oral administration of 20 mg rosuvastatin for at least 3 months
Study: NCT05273632

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin
Description: trial of reduction of losing blood intra operative or post operative during Cesarean Delivery

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oxytocin
Description: trial of reduction of losing blood intra operative or post operative during Cesarean Delivery

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin
Description: trial of reduction of losing blood intra operative or post operative during Cesarean Delivery
Study: NCT05009303

Intervention type: DEVICE
Intervention: OneStep Smartphone App and C-Mill Treadmill
Description: OneStep technology is a smartphone application that utilizes smartphone sensors to provide ongoing gait diagnostics. Each participant will have two sessions, during which, they will walk on a C-Mill smart treadmill for up to 15 minutes (with a minimum of 2 minutes), while carrying 2 smartphones and being recorded via two video cameras. The second walking session, conducted under similar conditions, will be used for test-retest reliability.
Study: NCT05543850

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bi-hormonal closed-loop control
Description: During bi-hormonal closed-loop control insulin and glucagon are administered to the developed closed-loop algorithm. Aditionally, patients will wear a blinded Dexcom G6 for data collection during the closed loop period.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Open-loop control
Description: During open-loop control the patients will use their usual diabetes therapy. Aditionally, patients will wear a blinded Dexcom G6 for data collection during the open loop period.
Study: NCT06211660

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AI-based AR training system
Description: Participants will use the AI-empowered AR training system to get individualized assessments of their hand wash performance. They will not be informed about the hand scanner results.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hand scanner and Video training
Description: Participants will use an existing education program that has been demonstrated effective in our previous study (unpublished). In brief, the participants will be informed about their hand scanner results during the first HW attempt. They will also watch a training video about the 7 steps of hand washing.
Study: NCT06576882

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vonoprazan
Description: Participants will receive Vonoprazan 20 mg tablets twice daily before meals.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan
Description: Participants will receive Vonoprazan 20 mg tablets twice daily before meals.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin
Description: Participants will receive Amoxicillin 50 mg/kg/day capsules or suspension \[maximum daily dose: 2 g\].

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Description: Participants will receive Amoxicillin 50 mg/kg/day capsules or suspension \[maximum daily dose: 2 g\].

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clarithromycin
Description: Participants will receive Clarithromycin 20 mg/kg/day tablets or suspension \[maximum daily dose: 1 g\].

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clarithromycin
Description: Participants will receive Clarithromycin 20 mg/kg/day tablets or suspension \[maximum daily dose: 1 g\].
Study: NCT05685459

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard patient simulation model
Description: Nursing students were trained with a standard patient simulation model for position and communication skills education.
Study: NCT05323539

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Evaluating Thyroid Volumes by ultrasonography
Description: The inclusion criteria are ; having a prediagnosis of surgically planned endometrioma and to undergo gynecological surgery for a reason other than endometriosis (control group). Among the patients with pre-diagnosis of endometriosis, who applied to our clinic during the study period and accepted to participate in the study, thyroid volumes will be measured by ultrasonography during the preoperative hospitalization. The pathological diagnosis of the patients will be confirmed and patients with different results will be excluded from the study (such as malignancy, endometriosis prediagnosis but different pathology detected etc.) In the same period, gynecological surgery was planned for another reason and patients without endometriosis will form the control group.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Evaluating Thyroid Volumes by ultrasonography
Description: The inclusion criteria are ; having a prediagnosis of surgically planned endometrioma and to undergo gynecological surgery for a reason other than endometriosis (control group). Among the patients with pre-diagnosis of endometriosis, who applied to our clinic during the study period and accepted to participate in the study, thyroid volumes will be measured by ultrasonography during the preoperative hospitalization. The pathological diagnosis of the patients will be confirmed and patients with different results will be excluded from the study (such as malignancy, endometriosis prediagnosis but different pathology detected etc.) In the same period, gynecological surgery was planned for another reason and patients without endometriosis will form the control group.
Study: NCT05488626

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Adaptive Radiotherapy
Description: Standard fractionation external beam radiotherapy (60-66 Gy in 2 Gy/fraction) with daily online adaptation.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Non-Adaptive Radiotherapy
Description: Standard fractionation external beam radiotherapy (60-66 Gy in 2 Gy/fraction) with daily image guidance.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: Concomitant chemotherapy per NCCN or other national guidelines.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy
Description: Concomitant chemotherapy per NCCN or other national guidelines.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Immunotherapy
Description: Adjuvant immunotherapy per national or institutional guidelines.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Immunotherapy
Description: Adjuvant immunotherapy per national or institutional guidelines.
Study: NCT04631263

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid
Description: Injectable gel. Chin correction and augmentation for retrusion
Study: NCT05821738

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avapritinib
Description: administered orally
Study: NCT04779138

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Increasing Willingness and Uptake of COVID-19 Vaccination
Description: Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to reduce COVID-19 vaccine hesitancy and increase willingness and uptake in COVID-19 vaccination.
Study: NCT04941040

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Opioid free anesthetics
Description: Patients will receive over the 10 minutes prior to induction:~* Acetaminophen 1 gm i.v. infusion in 100ml over 10 minutes.~* Ketorolac 30 mg i.v. infusion in100 ml over 10 minutes.~* Mg SO4 loading dose 30 mg/kg i.v. infusion in 100 ml over 10 minutes.~* Dexmedetomidine loading dose 1 μg/kg i.v. infusion.~* Lidocaine loading dose 1.5 mg/kg i.v. infusion.~* Ketamine loading dose 0.25 mg/kg i.v. infusion.~The weight based doses of dexmedetomidine, lidocaine, ketamine will be prepared on 20 ml syringe and infused over 10 minutes prior to induction. In a dose of 0.1 ml/kg~Then after induction maintenance analgesic infusion will start in a rate that ranges from 0.025 to 0.05 ml/kg/h which is equivalent to:~* Dexmedetomidine 0.25-0.5 μg/kg/h~* Lidocaine 0.375-0.75 mg/kg/h~* Ketamine 0.0625- 0.125 mg/kg/h

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Opioid Anesthetics
Description: Placebo equivalent to acetaminophen, ketorolac, magnesium sulphate will be infused as 100 ml normal saline each over 10 minutes ,patients will receive fentanyl 2 μg/kg loading dose which will be prepared over 20 ml syringe and infused over 10 minutes prior to induction, Then after induction maintenance of analgesic infusion by fentanyl 0.5-1 μg/kg/h.
Study: NCT05620212

Intervention type: BEHAVIORAL
Intervention: Recovery College participation
Description: Recovery College participation in any way (visitors, course/retreat participants, volunteers, employees).
Study: NCT06268158

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Eye patch
Description: The experimental group will fill out the patient introduction form, Richmond Agitation-Sedation Scale, Nursing Delirium Screening Scale and Richard-Campbell Sleep Scale on the first day. On the 4th day of the study, the Nursing Delirium Screening Scale and the Richard-Campbell Sleep Scale will be completed.
Study: NCT06579898

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive resistance exercise training
Description: A 24-week progressive strength training programme (PRET). Divided into 4 mesocycles in which the intensity of training is built up from 60% 1RM- 80% 1RM. Training is carried out twice a week under the guidance of a physiotherapist or exercise instructor.
Study: NCT06054659

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Real Time Continuous Glucose Monitoring (rt-CGM)
Description: Participants randomized to rt-CGM will have CGM placed prior to hospital discharge. They will also receive teaching from the research team on the proper use of their CGM sensor and reader. The study team will CGM devices but subjects may use their own glucometer for FBG testing as needed including for CGM calibration.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fingerstick blood glucose (FBG) monitoring
Description: Participants will use their own glucometer for FBG testing as advised by their treating provider (usually primary care or diabetes doctor).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fingerstick blood glucose (FBG) monitoring
Description: Participants will use their own glucometer for FBG testing as advised by their treating provider (usually primary care or diabetes doctor).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diabetes Education
Description: Participants will receive standard-of-care diabetes education with a certified diabetes educator (CDE) prior to discharge (with the approval of the treating inpatient team).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diabetes Education
Description: Participants will receive standard-of-care diabetes education with a certified diabetes educator (CDE) prior to discharge (with the approval of the treating inpatient team).
Study: NCT05167266

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducation
Description: Psychoeducation refers to the process of providing education and information to those seeking or receiving mental health services.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Description: Psychoeducation refers to the process of providing education and information to those seeking or receiving mental health services.
Study: NCT04775914

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PCI + Ischemic conditioning
Description: IPOST is repeated for 4 cycles (60 sec obstruction followed by 60 sec perfusion each) and followed by stent implantation with a 1.1/1.0 ratio of stent diameter/reference vessel diameter and a stent length sufficient to cover the entire lesion from healthy to healthy area of the vessel. During the first cycle of re-occlusion of full vessel occlusion is secured by a small injection of contrast.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PCI + Ischemic conditioning
Description: IPOST is repeated for 4 cycles (60 sec obstruction followed by 60 sec perfusion each) and followed by stent implantation with a 1.1/1.0 ratio of stent diameter/reference vessel diameter and a stent length sufficient to cover the entire lesion from healthy to healthy area of the vessel. During the first cycle of re-occlusion of full vessel occlusion is secured by a small injection of contrast.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stent with ultrasound
Description: IVUS catheters are to be advanced at least 20 mm distal to the culprit lesion. After administration of intracoronary nitroglycerine, an IVUS-pullback is to be performed at 0.5mm/second using a commercially available imaging system. Stent size and landing zones are decided based on the IVUS.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Stent with ultrasound
Description: IVUS catheters are to be advanced at least 20 mm distal to the culprit lesion. After administration of intracoronary nitroglycerine, an IVUS-pullback is to be performed at 0.5mm/second using a commercially available imaging system. Stent size and landing zones are decided based on the IVUS.
Study: NCT05389566

Intervention type: DIAGNOSTIC_TEST
Intervention: Accelerometer
Description: Evaluation of gait pattern

Intervention type: DIAGNOSTIC_TEST
Intervention: Handgrip strength
Description: Evaluation of muscle strength

Intervention type: DIAGNOSTIC_TEST
Intervention: Handgrip strength
Description: Evaluation of muscle strength

Intervention type: DIAGNOSTIC_TEST
Intervention: Handgrip strength
Description: Evaluation of muscle strength

Intervention type: DIAGNOSTIC_TEST
Intervention: Dual Energy X-ray Absorbtimetry scan
Description: Evaluation of body composition

Intervention type: DIAGNOSTIC_TEST
Intervention: Dual Energy X-ray Absorbtimetry scan
Description: Evaluation of body composition

Intervention type: DIAGNOSTIC_TEST
Intervention: Dual Energy X-ray Absorbtimetry scan
Description: Evaluation of body composition
Study: NCT06185933

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine Spray
Description: Pharyngeal anesthesia using a topical lidocaine spray was administered in the preprocedure room, in the absence of the endoscopist or the research assistant. 5 minute before the UGE without any sedation

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine Viscous+Lidocane spray
Description: Pharyngeal anesthesia using topical viscous lidocaine solution + lidocaine spray were administered in the preprocedure room, in the absence of the endoscopist or the research assistant. 5 minute before the UGE without any sedation
Study: NCT04873648

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: caloric reduced -intermitted fasting diet
Description: obese women with food addiction and binge eating follow intermittent calorie restriction diet ( time-restricted eating - typically 16 -hour fasting and 8-hour eating)
Study: NCT05389566

Intervention type: DIAGNOSTIC_TEST
Intervention: Force Plate Platform
Description: Evaluation of balance while standing still

Intervention type: DIAGNOSTIC_TEST
Intervention: Force Plate Platform
Description: Evaluation of balance while standing still

Intervention type: DIAGNOSTIC_TEST
Intervention: Force Plate Platform
Description: Evaluation of balance while standing still
Study: NCT04873648

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: caloric reduced -intermitted fasting diet
Description: obese women with food addiction and binge eating follow intermittent calorie restriction diet ( time-restricted eating - typically 16 -hour fasting and 8-hour eating)

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Daily calorie restriction
Description: obese women with food addiction and binge eating disorder follow a Daily calorie restriction diet

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Daily calorie restriction
Description: obese women with food addiction and binge eating disorder follow a Daily calorie restriction diet

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Control group
Description: obese women without food addiction and binge eating disorder follow a Daily calorie restriction diet
Study: NCT06184828

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Whole blood transfusion
Description: The transfusion of whole blood units

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Blood components transfusion
Description: The transfusion of blood components units rather than whole blood
Study: NCT05947929

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic excise
Description: the treadmill exercises three times a week for 12 weeks) based on the Following protocol: Intensity exercise: determined by karvonen formula: Exercise heart rate = \[(A-B) × desired intensity\] + B \[A represents maximum heart rate (220-age) and B for resting heart rate (average of three measurements)\]. The desired intensity will be at 50- 70%. Heart rate was measured by pulse-meter to detect pulse rate before exercise (Resting HR)\].

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: acupuncture
Description: the acupuncture needles will be inserted through the adhesive pads. The acupuncture needles used in the study are 40 mm in length and 0.30 mm in diameter and manufactured by Suzhou Hwato Medical Instruments Co. Ltd (Suzhou, China). The following acupoints will be used: DU20 (Baihui), ST36 (Zusanli), ST37 (Shangjuxu), SP6 (Sanyinjiao), ST25 (Tianshu), and LR3 (Taichong).
Study: NCT06643884

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser
Description: Laser Administration

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser
Description: Laser Administration